The application of behavioral science and health communications best practices is vital to the success of research studies that require assessment of psychosocial constructs and biobehavioral correlates of stress, along with the integration of complex cancer-related information, counseling, and targeted/tailored health-related messages. Increasingly, this research also needs to include participatory research practices to form interactive and sustainable partnerships. The Behavioral Research Core Facility (BRCF) was established to provide a structured mechanism for integrating behavioral science into the broader science research activities conducted through the Medical and Population Science Divisions at Fox Chase Cancer Center (FCCC). Currently, the Facility provides services to 20 FCCC investigators, 85% of whom receive peer-reviewed funding, across six research Programs and two Divisions. The BRCF helps peer-reviewed, funded investigators apply innovative theory-driven behavioral and social science research designs, measurements, data collection techniques, and analytic methods into the planning, implementation, and dissemination of FCCC research endeavors. Specifically, the BRCF's purpose is to facilitate psychosocial assessment and intervention research in the areas of: 1) adaptation, stress and coping, quality of life, and quality of care; 2) decision making (e.g., about cancer risk assessment and genetic testing, risk reduction and treatment options, and clinical trial participation); 3) adherence to prevention, screening, diagnostic, treatment, and follow-up recommendations; and 4) behavioral lifestyle changes (e.g., smoking cessation). Facilitation and support for dissemination and community-based research is provided through the BRCF's collaborations with community-focused organizations. The BRCF specialists facilitate research in, and access to, community settings with diverse populations, based on established strategies and principles of successful partnerships, for FCCC investigators who otherwise would not have access to these resources The BRCF staff is uniquely qualified to provide these services, since they have expertise in behavioral principles and methodologies, and in the development and production of traditional and novel media approaches to cancer and health. The BRCF's resources are readily available to all investigators who conduct research that includes behavioral science approaches as factors or endpoints.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA006927-44
Application #
7310520
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
44
Fiscal Year
2006
Total Cost
$81,600
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
073724262
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Gupta, Sapna; Kelow, Simon; Wang, Liqun et al. (2018) Mouse modeling and structural analysis of the p.G307S mutation in human cystathionine ?-synthase (CBS) reveal effects on CBS activity but not stability. J Biol Chem 293:13921-13931
Sementino, Eleonora; Menges, Craig W; Kadariya, Yuwaraj et al. (2018) Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. J Cell Physiol 233:8952-8961
Araiza-Olivera, Daniela; Chernoff, Jonathan (2018) Hras helps hippo heterodimerize to evade tumor suppression. Small GTPases 9:327-331
Peng, Hongzhuang; Prokop, Jeremy; Karar, Jayashree et al. (2018) Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res 78:1200-1213
Reese, Jennifer Barsky; Smith, Katherine Clegg; Handorf, Elizabeth et al. (2018) A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors. J Psychosoc Oncol :1-22
Shaikh, Talha; Handorf, Elizabeth A; Meyer, Joshua E et al. (2018) Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults. JAMA Oncol 4:e173580
Roy, Anuradha (2018) Early Probe and Drug Discovery in Academia: A Minireview. High Throughput 7:
Auerbach, M V; Heckman, C J; Darlow, S (2018) To protect or not to protect: examining reasons for sun protection among young women at risk for skin cancer. J Behav Med 41:528-536
Diefenbach, Michael A; Benedict, Catherine; Miller, Suzanne M et al. (2018) Examining the impact of a multimedia intervention on treatment decision-making among newly diagnosed prostate cancer patients: results from a nationwide RCT. Transl Behav Med 8:876-886
Ross, Kayleigh C; Chin, Kevin F; Kim, Daehwan et al. (2018) Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib. Oncotarget 9:13324-13336

Showing the most recent 10 out of 1280 publications